Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Korea’s GC Labs announces plans to expand in the Middle East ahead of their participation in Medlab Middle East 2022

Article-Korea’s GC Labs announces plans to expand in the Middle East ahead of their participation in Medlab Middle East 2022

Seminar by GC Labs at Medlab will examine the fight against pandemics and infectious diseases and the importance of public and private sector partnership

The increase in demand for genetics and infectious disease tests in the region has prompted South Korea’s GC Labs, a leading clinical diagnostics company, to plan further expansion in the Middle East. Currently offering their services in Saudi Arabia and the UAE, the company is in talks with regional partners to expand their services to more countries in the Middle East. More than 800 employees at GC Labs offer over 5,000 tests and test combinations, ranging from routine tests to highly esoteric molecular and genetic assays.

To create further awareness of their services, GC Labs will participate in the 2022 edition of Medlab Middle East at Dubai World Trade Centre (DWTC) from January 24-27. At the event, GC Labs will highlight its “smart lab” concept that provides an automated test system to improve speed and efficiency of tests, allowing the company to report results in just a day or two.

Eun-Hee Lee, President at GC Labs, says: “The Middle East is an important market for us, and participating in Medlab will help us to share our best practices in clinical diagnostics with the regional health community. Over the past two decades, the world has achieved important success in the fight against pandemics like COVID-19 and in mobilising global response against HIV-Aids, TB, Malaria and other infectious diseases. Medical laboratories play a key role in this fight by providing high quality diagnostic testing and by working in partnership with the health authorities. To highlight the importance of private and public partnership in the fight against infectious diseases and pandemics, we are organising a seminar during Medlab to bring together international experts to share their own experiences and expertise, focus on lessons learned, and discuss how to best manage public and private partnerships to successfully fight against pandemics and infectious diseases in the future.”

Eun Hee Lee, President at GC Labs.jpg

Image supplied, Eun-Hee Lee, President at GC Labs

GC Labs will host its seminar on ‘Public-Private Partnership in Global Health: bringing the best of both worlds to improve testing’ on 25th January at the Bubble Lounge in Medlab. The seminar has an impressive line-up of speakers with globally renowned specialists including Lelio Marmora, former CEO in Unitaid;  Pr. Michel Kazatchkine, former executive director the Global Fund to Fight AIDS, TB and Malaria; Dr. Eskild Petersen, MD, Editor-in-chief of IJID Regions, an official journal of the International Society for Infectious Diseases (ISID); Dr. Amina Al-Jardani, Director of Central Public Health Laboratories (CPHL), Directorate General for Disease Surveillance and Control, Ministry of Health, Oman; and Eun-hee Lee, President at GC Labs.  The seminar will be an interactive session with an opportunity for attendees to ask questions.

From January 24-27, GC Labs will be present at booth Z4.E42 in Medlab where they will offer a ‘smart experience’ for visitors to learn more about the diagnostic services the company offers.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.